---
title: RNF40 epigenetically modulates glycolysis to support the aggressiveness of
  basal-like breast cancer
date: '2023-09-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37770435/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230929180838&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Triple-negative breast cancer (TNBC) is the most difficult breast cancer
  subtype to treat due to the lack of targeted therapies. Cancer stem cells (CSCs)
  are strongly enriched in TNBC lesions and are responsible for the rapid development
  of chemotherapy resistance and metastasis. Ubiquitin-based epigenetic circuits are
  heavily exploited by CSCs to regulate gene transcription and ultimately sustain
  their aggressive behavior. Therefore, therapeutic targeting of these ubiquitin-driven
  ...
disable_comments: true
---
Triple-negative breast cancer (TNBC) is the most difficult breast cancer subtype to treat due to the lack of targeted therapies. Cancer stem cells (CSCs) are strongly enriched in TNBC lesions and are responsible for the rapid development of chemotherapy resistance and metastasis. Ubiquitin-based epigenetic circuits are heavily exploited by CSCs to regulate gene transcription and ultimately sustain their aggressive behavior. Therefore, therapeutic targeting of these ubiquitin-driven ...